New evidence–based clinical practice guidelines from the Alzheimer’s Association provide updated recommendations on evaluating individuals suspected of having Alzheimer’s disease (AD) and AD ...
In a bid to revolutionize Alzheimer’s detection, scientists have examined the brain’s neurovascular unit. The research ...
The Alzheimer’s disease market is expected to grow at a high compound annual growth rate (CAGR) of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the eight major markets (8MM) (US ...
Research has revealed clear evidence that changes in the orchestration of brain oxygenation dynamics and neuronal function in Alzheimer's disease contribute to the neurodegeneration. Researchers found ...